Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy

被引:38
作者
Brotherton, Julia M. L. [1 ,2 ]
Kaldor, John M. [3 ]
Garland, Suzanne M. [4 ,5 ,6 ,7 ]
机构
[1] Victorian Cytol Serv, Melbourne, Vic 8002, Australia
[2] Univ Sydney, Natl Ctr Immunisat Res & Surveillance, Childrens Hosp Westmead, Discipline Paediat & Child Hlth,Sch Publ Hlth, Sydney, NSW 2006, Australia
[3] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia
[4] Royal Womens Hosp, Melbourne, Vic 3052, Australia
[5] Royal Childrens Hosp, Dept Clin Microbiol, Melbourne, Vic 3052, Australia
[6] Univ Melbourne, Fac Med Dent & Hlth, Dept Obstet & Gynaecol, Melbourne, Vic 3053, Australia
[7] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia
关键词
cervical cancer; genital warts; Pap smears; recurrent respiratory papillomatosis; vaccination; vaccine safety; RECURRENT RESPIRATORY PAPILLOMATOSIS; CERVICAL INTRAEPITHELIAL NEOPLASIA; VACCINE SAFETY; CANCER; IMMUNIZATION; ADOLESCENT; PREVALENCE; LESIONS; COHORT; WOMEN;
D O I
10.1071/SH09137
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This paper describes a possible multifaceted approach to human papillomavirus (HPV) related surveillance in Australia following implementation of a national HPV vaccination program. We describe eight main components: monitoring of vaccine coverage, vaccine safety, type-specific HPV infection surveillance, cervical cytology (Pap screening) coverage and screen detected lesion prevalence, cervical cancer incidence and mortality, genital wart incidence, incidence of recurrent respiratory papillomatosis, and knowledge, attitudes and beliefs about HPV and HPV vaccination. Australia is well placed to monitor the impact of its HPV vaccination program as well as to measure vaccine effectiveness with existing HPV vaccines, cervical screening and cancer registries.
引用
收藏
页码:310 / 319
页数:10
相关论文
共 38 条
[1]  
*AIHW, 2009, CANC SER AIHW, V47
[2]  
Alam N, 2008, CERVICAL CANC SCREEN
[3]  
[Anonymous], 2009, Wkly Epidemiol Rec, V84, P118
[4]   Human papillomavirus genotypes and their association with cervical neoplasia in a cohort of Western Australian women [J].
Brestovac, B ;
Harnett, GB ;
Smith, DW ;
Shellam, GR ;
Frost, FA .
JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (01) :106-110
[5]   Predictors of HPV vaccine acceptability: A theory-informed, systematic review [J].
Brewer, Noel T. ;
Fazekas, Karah I. .
PREVENTIVE MEDICINE, 2007, 45 (2-3) :107-114
[6]   How much cervical cancer in Australia is vaccine preventable? A meta-analysis [J].
Brotherton, Julia M. L. .
VACCINE, 2008, 26 (02) :250-256
[7]   Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination [J].
Budd, Alison C. ;
Sturrock, Christine J. .
SEXUAL HEALTH, 2010, 7 (03) :328-334
[8]   Models of cervical screening in the era of human papillomavirus vaccination [J].
Canfell, Karen .
SEXUAL HEALTH, 2010, 7 (03) :359-367
[9]   Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia-Grade 2 [J].
Castle, Philip E. ;
Schiffman, Mark ;
Wheeler, Cosette M. ;
Solomon, Diane .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2009, 64 (05) :306-308
[10]  
CDC, 2001, Morbidity and Mortality Weekly Report, V50, P1